Longboat Amniotics (private company)

See something wrong or missing? Let us know
Offices:Lund
Registration number:559024-6558
Industry:Biotech
Business model:B2B

Longboat Amniotics, formerly named Longboat Explorers, is based on the work of researchers Marcus Larsson, Andreas Herbst and Niels-Bjarne Woods at Lund University, who discovered a new type of stem cells in amniotic fluid that have unique properties for applications in regenerative medicine.

The company invented and patented a method for utilizing these new stem cells, including further processing and final use for medical applications.

Investors: we tracked 4 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 2.12M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Longboat Amniotics

Name Criteria
Sweden Cartana
45%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one other investor: Almi Invest
  • Total raised in a similar range: 1M - 5M USD
Sweden EMPE Diagnostics AB
45%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one other investor: Almi Invest
  • Total raised in a similar range: 1M - 5M USD
Sweden Gedea Biotech
45%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one other investor: Almi Invest
  • Total raised in a similar range: 1M - 5M USD
Sweden LipUm
45%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one other investor: Almi Invest
  • Total raised in a similar range: 1M - 5M USD
Sweden BiBB Instruments
38%
  • Similar business models: B2B
  • At least one angel investor: Christer Fahraeus
  • At least one other investor: Almi Invest
Spain AptaTargets
35%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Sweden Athera
35%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
France BeFC
35%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
United Kingdom Better Dairy
35%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Denmark Biograil
35%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Top